In a nutshell The study compared patients who had holmium enucleation of the prostate (HoLEP – laser removal of prostate tissue) as their first treatment for an enlarged prostate (primary), with patients who used HoLEP after other treatments failed (retreatment). The study found that retreatment with HoLEP was safe and effective but with a...
Read MoreBenign prostatic hyperplasia Posts on Medivizor
5-alpha reductase inhibitors may be linked with depression, but not suicidality
In a nutshell This study examined a possible link between suicidality and depression and the use of 5-alpha reductase inhibitors (5ARIs) for benign prostatic hyperplasia (BPH). Researchers reported no link between suicide risk and 5ARI use. However, the risk of self-harm and depression was significantly increased among men using a 5ARI compared to men...
Read MoreCombining flomax and cialis can effectively treat urinary symptoms as well as erectile dysfunction
In a nutshell This study examined whether combining tadalafil (Cialis) and tamsulosin (Flomax) can reduce both urinary symptoms as well as erectile dysfunction. This treatment combination was safe and effective in reducing urinary symptoms and improving erectile function. Some background Many men with benign prostatic hyperplasia (BPH) experience...
Read MoreProstate Cancer Awareness Month
September is Prostate Cancer Awareness Month. To increase awareness, Medivizor is sharing a theory from researchers at Johns Hopkins University School of Medicine that attempts to explain what may be causing men in Europe and the US to be so vulnerable to prostate cancer. What does the prostate gland do? The prostate gland is part of the male...
Read MoreAdding Cialis to alpha-blocker therapy can improve urinary symptoms
In a nutshell This study examined the effects of combining tadalafil (Cialis) with silodosin (Rapaflo) for benign prostatic hyperplasia (BPH). Researchers reported improved urinary symptoms when tadalafil was added to silodosin treatment compared to silodosin alone. Some background Men with BPH often experience urinary symptoms that can...
Read MoreB-TUEP: A new minimally invasive procedure for BPH
In a nutshell This study examined the effects of B-TUEP, a new minimally invasive procedure to treat benign prostate hyperplasia (BPH). Researchers concluded that B-TUEP is a safe, durable, and effective alternative treatment option for BPH. Some background BPH can lead to bothersome urinary symptoms that impact quality of life. Surgery is often...
Read MoreFDA News Releases and Signing Up for Alerts
You may not know this but you can get warnings from the FDA on problems with prescription medications and over-the-counter drugs. For example, on August 11, a FDA News Release issued this warning about over-the-counter liquid vitamins that are given to young children and those who cannot swallow pills. “The U.S. Food and Drug Administration is...
Read MoreAn overview of urinary symptoms in Parkinson disease and multiple system atrophy
In a nutshell This study summarized the occurrence and treatment of urinary symptoms in patients with Parkinson disease (PD) and multiple system atrophy (MSA). Some background Urinary incontinence is a bothersome symptom that can have a considerably impact on quality of life. It can have various causes, including disorders of the central nervous...
Read MoreTamsulosin, dutasteride and imidafenacin – a promising new treatment combination for BPH
In a nutshell This study examined the effects of combining 3 different types of therapies – tamsulosin (Flomax), dutasteride (Avodart), and imidafenacin (Uritos) – in the treatment of benign prostatic hyperplasia (BPH). Authors concluded that this treatment combination is safe and effective in reducing urinary symptoms caused by BPH. Some...
Read MoreSevere urinary symptoms are associated with increased cardiovascular risk
In a nutshell This study examined the association between cardiovascular disease (CVD) and the presence of urinary symptoms. Researchers reported a significant increase in the 10-year CVD risk among men with severe urinary symptoms, after controlling for other risk factors. Some background The occurrence and symptoms of benign prostatic...
Read MoreTamsulosin versus naftopidil: Comparing alpha-blockers for BPH
In a nutshell This study compared two types of alpha-blockers – tamsulosin (Flomax) and naftopidil (Avodart) – in the treatment of benign prostatic hyperplasia (BPH). Researchers reported similar improvements in urinary symptoms across the two treatment groups. Some background BPH can cause bothersome urinary symptoms that affect...
Read MoreColon Cancer Patient Advocate Shares Her Story
In April, the American Association for Cancer Research (AACR) held a free education event on cancer called Progress and Promise Against Cancer in Washington, D.C. Surrounded by experts in cancer research, Kim Hall Jackson shared her patient story. One evening in 2008, Jackson, an event planner, was running the mayor’s inaugural event in...
Read More